Sponsor Pipeline

Shanghai Qilu Pharmaceutical Research and Development Center LTD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
3
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-12 NCT07760077 Phase I Study of QLS1510 Tablets in Healthy Participants Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06946641 A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in… Atopic Dermatitis Recruiting
NCT07552376 This Study Aims to Evaluate the Efficacy and Safety of QLS1317 in Patients With… MSI-H or dMMR Advanced Solid Tumors Not Yet Recruiting
NCT07760077 Phase I Study of QLS1510 Tablets in Healthy Participants Inflammatory Bowel Disease (IBD) Not Yet Recruiting
Disease Areas
Rheumatoid Arthritis (1) Atopic Dermatitis (1) Hidradenitis Suppurativa (1)
Get alerts when Shanghai Qilu Pharmaceutical Research and Development Center LTD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free